shortagewatch

Home / Sertraline / Italy

IT ATC N06AB06 · updated 2 Nov 2026

Sertraline shortage in Italy

Is there a Sertraline shortage in Italy?

Yes. As of 2 Nov 2026, 14 Sertraline products are reported short in Italy, the first since 5 Aug 2022. The company estimate for the return is 31 Dec 2026 (latest 31 Mar 2027). Main reason: manufacturing problem.

Also short in Canada, Germany, Spain, Ireland, Austria, Belgium, Czechia, Sweden, Japan, Australia. All countries.

Affected products in Italy

CountryProductCompanySinceExpected backReason
ITSERTRALINA ZENTIVAZENTIVA ITALIA S.R.L.5 Aug 2022not givenIncreased demand
Elevata richiesta
ITSERTRALINA ZENTIVAZENTIVA ITALIA S.R.L.31 Dec 2023not givenManufacturing problem
Problemi produttivi
ITSERTRALINA ALMUSALMUS S.R.L.31 Aug 202431 Dec 2026Manufacturing problem
Problemi produttivi
ITSERTRALINA MYLAN GENERICSMYLAN S.P.A.4 Nov 2024not givenManufacturing problem
Problemi produttivi
ITSERTRALINA MYLAN GENERICSMYLAN S.P.A.21 Nov 2024not givenManufacturing problem
Problemi produttivi
ITSERTRALINA MYLAN GENERICSMYLAN S.P.A.3 Mar 2025not givenManufacturing problem
Problemi produttivi
ITSERTRALINA ALMUSALMUS S.R.L.1 Apr 202531 Dec 2026Manufacturing problem
Problemi produttivi
ITSERTRALINA MYLAN GENERICSMYLAN S.P.A.5 May 2025not givenManufacturing problem
Problemi produttivi
ITSERTRALINA ACCORDACCORD HEALTHCARE, S.L.U.22 Oct 2025not givenIncreased demand
Elevata richiesta/problemi produttivi
ITSERTRALINA ACCORDACCORD HEALTHCARE, S.L.U.9 Mar 2026not givenIncreased demand
Elevata richiesta
ITSERTRALINA DOC GENERICIDOC GENERICI SRL31 Aug 2026not givenIncreased demand
Elevata richiesta
ITSERTRALINA AUROBINDOAUROBINDO PHARMA (ITALIA) S.R.L.10 Sep 2026not givenManufacturing problem
Problemi produttivi
ITSERTRALINA PENSATOWA PHARMACEUTICAL S.P.A.15 Oct 202631 Mar 2027Increased demand
Elevata richiesta
ITZOLOFTVIATRIS PHARMA S.R.L.21 Oct 2026not givenIncreased demand
Elevata richiesta

Source

AIFA (Italian Medicines Agency), licensed CC-BY 4.0. Official list. All shortages reported by marketing-authorisation holders, including medicines being withdrawn.